MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

Oct 2017| BIO115C| BCC Publishing
Ask a Question

Report Highlights

The global market for microRNA tools reached $756.5 million and $829.8 million in 2015 and 2016, respectively. This market is estimated to reach nearly $1.4 billion in 2021 at a compound annual growth rate (CAGR) of 10.5% for 2016-2021. 

Report Includes

  • An overview of the global market for microRNA diagnostics and therapeutics, with an analysis of the commercial potential of this research field
  • Analyses of global market trends, with data from 2014, 2015, and 2016, and projections of compound annual growth rates (CAGRs) through 2021
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in different areas of medicine, such as cancer, hepatitis infections, and cardiovascular diseases
  • A focus on recent drug candidates, products, deals between different pharmaceutical companies, major participants, and new trends and developments
  • Identification of the main markets for RNA therapeutics

Report Scope

This report focuses on the global market of miRNA tools and provides an updated review including its applications in various arenas of diagnostics and therapeutics. The report deals with miRNA tools covering technologies used in the biomedical industry. These products are miRNA microarray, quantitative reverse transcription–PCR, next–generation sequencing, fluorescent in situ hybridization, isolation, purification, detection tools and other tools like inhibitors, probes and vectors.

The report also covers miRNA tools by end user and applications. The end users for miRNA tools are categorized as research, diagnostics, therapeutics, and service sectors. The report covers market application areas, such as cancer diseases, cardiovascular diseases, immunological diseases, neurological diseases, metabolic disorders and others (virology, endocrinology, plant science and genetic disease fields).

The scope of the study is global. BCC Research analyzes each market and its application, new products and advancements, market projections and market shares. The geographical regions covered in the report are the United States, Europe and emerging markets. The emerging market covers countries such as India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, and Canada among others.

Also included in the report are relevant patent analysis, new products and developments and comprehensive profiles of companies that lead the industry. Notable players in this category are Thermo Fisher Scientific, Agilent Technologies, Qiagen N.V., Illumina Inc., F. Hoffmann–La Roche AG, and Bio–Rad Laboratories Inc.

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Latest reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price Member Price
Full Report: MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets 155 $2,500 Free
Chapter- 1: Introduction7Free
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market and Technology Background28$458Free
Chapter- 4: Market Breakdown by Technology Type 9$147Free
Chapter- 5: Market Breakdown by End User16$261Free
Chapter- 6: Market Breakdown by Application20$327Free
Chapter- 7: Market Breakdown by Region18$294Free
Chapter- 8: Industry Structure11$180Free
Chapter- 9: Patent Review/ New Developments13$212Free
Chapter- 10: Analysis of Market Opportunities4$65Free
Chapter- 11: Company Profiles24$392Free
Chapter- 12: Appendix: Abbreviations2$33Free
Published - Sep-2014| Analyst - Natana Raj| Code - BIO115B

Report Highlights

The global market for microRNA (miRNA) research tools, services, diagnostics and drug discovery was valued at $478.8 million in 2013. This market is expected to reach $572 million in 2014 and $1 billion in 2019, at a compound annual growth rate (CAGR) of 12.6% for the period of 2014 to 2019.

Report Includes

  • An overview of the global market for microRNA diagnostics and therapeutics with an analysis of the commercial potential of this research field.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in different areas of medicine, such as cancer, HCV infection, and cardiovascular diseases.
  • A focus on recent drug candidates, products, deals between different pharmaceutical companies, major participants, and new trends and developments.
  • Identification of the main markets for RNA therapeutics.
Published - Nov-2012| Analyst - Marianna Tcherpakov| Code - BIO115A

Report Highlights

The global microRNA research tools market was valued at nearly $295.1 million in 2011 and should reach nearly $338.3 million in 2012. Total market value is expected to reach $763 million in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 17.7%.

Report Includes

  • An overview of the global market for microRNA diagnostics and therapeutics with an analysis of the commercial potential of this research field
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in different areas of medicine, such as cancer, HCV infection, and cardiovascular diseases
  • A focus on recent drug candidates, products, deals between different pharmaceutical companies, major participants, and new trends and developments during the last two years
  • Forecasts of the future situation and major drawbacks of the miRNA drug development model and possible solutions for these obstacles, especially in context of drug stability and delivery
  • Identification of the main markets for RNA therapeutics
  • Comprehensive company profiles of major players in the industry.

When do I get the report?
Most reports are fulfilled immediately. In some cases, it could take up to 24 hours.

In what format does this report get delivered to me?
We will send you an email with login credentials to access the report. You will also be able to download the pdf.

What are the free reports included in my purchase?
They consist of a collection of current reports from various partner publishers scanning multiple industries.

What is the difference between BCC Research and BCC Publishing?
BCC Research curates thousands of reports from different sources and provides access to this content to our clients. BCC Publishing is the publication arm of BCC Research (one of several publishers in our portal).

What reports do I get 'discounts' on with my purchase?
All reports. BCC Publishing reports will be available for a 50% discount. All other partner publishers are also available at deeply discounted rates.

Where are you located?
Wellesley Massachusetts, just outside of Boston, Massachusetts, USA.

How long has BCC Research been around?
We are approaching our 50 year anniversary in 2021!

What if I want you to invoice me for payment via Purchase Order?
Simply choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

What if I have a question about your reports?
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times, and included in every purchase, to help our customers find the research they need-when they need it.

Can I share this report with my team?
Absolutely yes, with the purchase of additional user licenses.

Can I use your research in my presentation?
Absolutely yes, so long as the publisher is properly cited.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report